The Food and Drug Administration (FDA) has approved a new presentation of Selarsdi ™ (ustekinumab-aekn), a biosimilar to ...

HealthDay News — Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, according to a research letter published online October 14 in the Journal of the American Medical Association.

The prevalence of obesity continues to remain high in the US making the demand for effective treatments even more urgent.

To help guarantee that women know of this new benefit, most private health plans would be required to disclose that over-the-counter contraception is covered without copayments, the White House noted.

CAM2029 is a novel depot formulation of octreotide, a somatostatin analogue, administered subcutaneously once monthly.